Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.
about
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015Current perspective on rituximab in rheumatic diseases.Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis.
P2860
Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Novel assessment tools to eval ...... e Rituximab in Myositis trial.
@ast
Novel assessment tools to eval ...... e Rituximab in Myositis trial.
@en
type
label
Novel assessment tools to eval ...... e Rituximab in Myositis trial.
@ast
Novel assessment tools to eval ...... e Rituximab in Myositis trial.
@en
prefLabel
Novel assessment tools to eval ...... e Rituximab in Myositis trial.
@ast
Novel assessment tools to eval ...... e Rituximab in Myositis trial.
@en
P2093
P2860
P1476
Novel assessment tools to eval ...... e Rituximab in Myositis trial.
@en
P2093
Adrienne L Yip
Anna V Jansen
Chester V Oddis
Heidi H Kong
Iren Horkayne-Szakaly
Joseph A Shrader
Maria L Turner
Minal S Jain
Rita Volochayev
Thomas A Fleisher
P2860
P304
P577
2014-07-28T00:00:00Z